Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1977-05-31
1979-06-26
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2603972, A61K 3159
Patent
active
041593260
ABSTRACT:
A process for the preparation of 5,6-cis- and 5,6-trans-10,19-dihydro-vitamin D derivatives which comprises hydrogenating a corresponding vitamin D compound in the presence of a ligand-coordinated homogeneous transition metal catalyst whereby the C-19 methylene group of the vitamin D compound is converted into a methyl group.
REFERENCES:
patent: 2942009 (1960-06-01), Westerhof
patent: 3049553 (1962-08-01), Schenck
patent: 3607888 (1971-09-01), DeLuca et al.
patent: 3697559 (1972-10-01), DeLuca et al.
patent: 3725489 (1973-04-01), Fuhrmann et al.
patent: 4011250 (1977-03-01), Ishikawa
Barton Derek H. R.
Hesse Robert H.
Love Ethel G.
Research Institute for Medicine & Chemistry Inc.
LandOfFree
Hydrogenation process for the preparation of 5,6 cis- and 5,6-tr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrogenation process for the preparation of 5,6 cis- and 5,6-tr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrogenation process for the preparation of 5,6 cis- and 5,6-tr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558643